drugset / Trial / NCT04942860
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to evaluate the influence of two concentrations of methotrexate on vitiligous lesions in patients with non-segmental vitiligo
Timeline
- Start
- 2019-10-01
- Primary completion
- 2023-06-01
- Completion
- 2023-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 0.5 % | Topical |
| Comparator | Methotrexate | Small molecule | 1 % | Topical |